search
Back to results

Affective Disorders: Eliminate WArning Signs And REstore Functioning: AWARE (AWARE)

Primary Purpose

Mood Disorders, Activities of Daily Living, Quality of Life

Status
Completed
Phase
Not Applicable
Locations
Denmark
Study Type
Interventional
Intervention
AWARE intervention
Sponsored by
Mental Health Services in the Capital Region, Denmark
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Mood Disorders focused on measuring Bipolar disorder, Mental disorder

Eligibility Criteria

18 Years - 65 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Diagnosis of bipolar disorder or unipolar disorder by ICD-10 diagnostic criteria (confirmed with a diagnostic interview), in a current state of remission (defined as HDRS-17 and YMRS scores of ≤ 14)
  • At inclusion participants must have objectively rated impaired functioning defined as a score ≥ 11 according to the Functioning Assessment Short Test (FAST).
  • Participants must be able to participate in 2/3 of the planned visits.

Exclusion Criteria:

  • Severe somatic disorder interfering with daily living
  • Ongoing alcohol or substance abuse
  • Dementia or inability to cooperate with the study, including inability to speak and read Danish.
  • ECT treatment within last 3 month

Sites / Locations

  • Psychiatric Centre North Zealand, Copenhagen University Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Intervention group

Control group

Arm Description

AWARE intervention

Treatment as usual (consisting of the standard out-patient mental health service routines in The Capital Region of Denmark)

Outcomes

Primary Outcome Measures

ADL ability
Assessment of Motor and Process Skills (AMPS) is a standardized observation-based assessment providing measures of the quality of ADL task performance.

Secondary Outcome Measures

Patient quality of Life
PSS (Cohen's Perceived Stress Scale) and WHOQoL (World Health Organization, Quality of life)
Daily functioning
FAST (Functioning Assessment Short Test) and WHODAS (WHO Disability Assessment Schedule 2.0)

Full Information

First Posted
January 6, 2021
Last Updated
October 20, 2023
Sponsor
Mental Health Services in the Capital Region, Denmark
search

1. Study Identification

Unique Protocol Identification Number
NCT04701827
Brief Title
Affective Disorders: Eliminate WArning Signs And REstore Functioning: AWARE
Acronym
AWARE
Official Title
Affective Disorders: Eliminate WArning Signs And REstore Functioning: AWARE
Study Type
Interventional

2. Study Status

Record Verification Date
October 2023
Overall Recruitment Status
Completed
Study Start Date
December 15, 2020 (Actual)
Primary Completion Date
February 1, 2023 (Actual)
Study Completion Date
September 30, 2023 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Mental Health Services in the Capital Region, Denmark

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Affective disorders are associated with impaired functioning and quality of life, as well as comorbid somatic disorders and increased mortality. Despite different medical and psychological treatment options, the prognosis for affective disorder remains largely unchanged. Consequently, the field needs new intervention strategies especially targeting the patient groups having impaired functioning. The core idea of the AWARE project is to focus on improving functioning and quality of life in patients with affective disorders every-day life using a comprehensive 360 degrees intervention. The trial has a randomized, controlled, parallel-group design. Study participants will be 140 outpatients, male or female age 18-65 with a diagnosis of bipolar disorder or unipolar disorder, in a current state of remission, with an objectively rated impaired functioning. Participant will be randomized to six month AWARE intervention or treatment as usual (TAU). Assessments encompassing Activities of Daily Living (ADL), neuropsychological testing, mood ratings, physical health and questionnaires on subjective cognitive complaints, psychosocial functioning, quality of life are, sleep quality and satisfaction with psychiatric treatment are carried out at baseline and after the end of treatment. Discussion: It is hypothesised that the AWARE arm in comparison with standard care will improve observed ability to perform Activities of Daily Living (ADL) and improve Quality of Life.
Detailed Description
Despite different medical and psychological treatment options, the prognosis for affective disorder remains largely unchanged. Consequently, the field needs new intervention strategies especially targeting the patient groups having impaired functioning. The core idea in the AWARE project is to focus on improving functioning and quality of life in patients with affective disorders every-day life using a comprehensive 360 degrees intervention. The present AWARE intervention represent an integrated treatment avenue to improve functioning in patients with affective disorders. The aim of the study is, in a pragmatically Randomised Controlled Trial (RCT), to investigate the effect of a 360 degrees intervention based on the ICF Brief Core Set for BD and unipolar disorder targeting functioning. The participants will upon inclusion, be randomised to participate in either 6 months AWARE treatment or standard care. The control group will receive standard care consisting of the standard out-patient mental health service routines in The Capital Region of Denmark. The AWARE intervention targets multiple aspects of the described enhancers of functioning based on on the ICF Brief Core Set, including ADL ability as a part of carrying out daily routines. The study carried out in a randomized design. The investigators who assess the patients are blinded to whether the patient has participated in the active or passive treatment arm, so the results will be valid. In addition, validated standardized survey methods according to all the outcomes is applied.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Mood Disorders, Activities of Daily Living, Quality of Life
Keywords
Bipolar disorder, Mental disorder

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
103 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Intervention group
Arm Type
Experimental
Arm Description
AWARE intervention
Arm Title
Control group
Arm Type
No Intervention
Arm Description
Treatment as usual (consisting of the standard out-patient mental health service routines in The Capital Region of Denmark)
Intervention Type
Combination Product
Intervention Name(s)
AWARE intervention
Intervention Description
Comprehensive 360 degrees intervention. The intervention targets multiple aspects of the described enhancers of functioning based on on the ICF Brief Core Set. 1) ADL ability as a part of carrying out daily routines 2) Mood symptoms, medication and side effects 3) Social, relatives and network 4) Physical health, including BMI, biomarkers and exercise5) Cognition, circadian rhythm measured as sleep quality, and coping (stress reduction).
Primary Outcome Measure Information:
Title
ADL ability
Description
Assessment of Motor and Process Skills (AMPS) is a standardized observation-based assessment providing measures of the quality of ADL task performance.
Time Frame
6 month
Secondary Outcome Measure Information:
Title
Patient quality of Life
Description
PSS (Cohen's Perceived Stress Scale) and WHOQoL (World Health Organization, Quality of life)
Time Frame
6 month
Title
Daily functioning
Description
FAST (Functioning Assessment Short Test) and WHODAS (WHO Disability Assessment Schedule 2.0)
Time Frame
6 month
Other Pre-specified Outcome Measures:
Title
Cognitive scores using a composite score from baseline to endpoint and physical health
Description
SCIP, DART and Trailmaiking
Time Frame
6 month

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Diagnosis of bipolar disorder or unipolar disorder by ICD-10 diagnostic criteria (confirmed with a diagnostic interview), in a current state of remission (defined as HDRS-17 and YMRS scores of ≤ 14) At inclusion participants must have objectively rated impaired functioning defined as a score ≥ 11 according to the Functioning Assessment Short Test (FAST). Participants must be able to participate in 2/3 of the planned visits. Exclusion Criteria: Severe somatic disorder interfering with daily living Ongoing alcohol or substance abuse Dementia or inability to cooperate with the study, including inability to speak and read Danish. ECT treatment within last 3 month
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Maj Vinberg, Prof, MD, DMSc
Organizational Affiliation
Psychiatric Centre North Zealand, Copenhagen University Hospital
Official's Role
Study Director
Facility Information:
Facility Name
Psychiatric Centre North Zealand, Copenhagen University Hospital
City
Hillerød
ZIP/Postal Code
3400
Country
Denmark

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.
IPD Sharing Time Frame
No current time frame
IPD Sharing Access Criteria
Reasonable request
Citations:
PubMed Identifier
35618335
Citation
Schwarz R, Decker L, Seeberg I, Miskowiak KW, Kessing LV, Vinberg M. Affective disorders: eliminate WArning signs and REstore functioning-AWARE-a randomised controlled multimodule intervention study, presentation of design and intervention. BMJ Open. 2022 May 26;12(5):e058839. doi: 10.1136/bmjopen-2021-058839.
Results Reference
derived

Learn more about this trial

Affective Disorders: Eliminate WArning Signs And REstore Functioning: AWARE

We'll reach out to this number within 24 hrs